Literature DB >> 2267888

Morbillivirus infections of seals during the 1988 epidemic in the Bay of Heligoland: III. Transmission studies of cell culture-propagated phocine distemper virus in harbour seals (Phoca vitulina) and a grey seal (Halichoerus grypus): clinical, virological and serological results.

T Harder1, T Willhaus, H R Frey, B Liess.   

Abstract

Eight harbour seals (Phoca vitulina), two of them seronegative, six seropositive against PDV and a seronegative grey seal (Halichoerus grypus) were exposed to a low doses of a cell culture-propagated phocine distemper virus isolate (PDV 2558/Han 88). An intranasal route of inoculation was chosen. Clinical signs, resembling those of 1988's seal disease and seroconversion were observed in both seronegative harbour seals. One of them succumbed to the infection. The virus was not transmitted to another susceptible harbour seal which served as in-contact animal. Virus could be recovered from leucocytes of the diseased seals. Viremia was also present in a seropositive harbour seal that developed mild clinical signs; other seropositive seals were protected from clinical disease. The grey seal showed seroconversion upon inoculation, but did not develop any signs of disease. The humoral immune response of the seals plainly discriminated between homologous (PDV) and heterologous (canine distemper virus, CDV) virus as shown by virus neutralization tests and an antibody-binding assay (PLA).

Entities:  

Mesh:

Year:  1990        PMID: 2267888

Source DB:  PubMed          Journal:  Zentralbl Veterinarmed B        ISSN: 0514-7166


  8 in total

1.  Analysis of antigenic differences between sixteen phocine distemper virus isolates and other morbilliviruses.

Authors:  T C Harder; V Moennig; I Greiser-Wilke; T Barrett; B Liess
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

2.  Rapid and sensitive detection of immunoglobulin M (IgM) and IgG antibodies against canine distemper virus by a new recombinant nucleocapsid protein-based enzyme-linked immunosorbent assay.

Authors:  V von Messling; T C Harder; V Moennig; P Rautenberg; I Nolte; L Haas
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

3.  Infection studies with canine distemper virus in harbour seals.

Authors:  V Svansson; M Blixenkrone-Møller; K Skirnisson; P Have; N I Heje; J Nielsen; E Lund
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

4.  Stage-structured transmission of phocine distemper virus in the Dutch 2002 outbreak.

Authors:  Petra Klepac; Laura W Pomeroy; Ottar N Bjørnstad; Thijs Kuiken; Albert D M E Osterhaus; Jolianne M Rijks
Journal:  Proc Biol Sci       Date:  2009-04-08       Impact factor: 5.349

Review 5.  Phocine distemper virus: current knowledge and future directions.

Authors:  Pádraig J Duignan; Marie-Françoise Van Bressem; Jason D Baker; Michelle Barbieri; Kathleen M Colegrove; Sylvain De Guise; Rik L de Swart; Giovanni Di Guardo; Andrew Dobson; W Paul Duprex; Greg Early; Deborah Fauquier; Tracey Goldstein; Simon J Goodman; Bryan Grenfell; Kátia R Groch; Frances Gulland; Ailsa Hall; Brenda A Jensen; Karina Lamy; Keith Matassa; Sandro Mazzariol; Sinead E Morris; Ole Nielsen; David Rotstein; Teresa K Rowles; Jeremy T Saliki; Ursula Siebert; Thomas Waltzek; James F X Wellehan
Journal:  Viruses       Date:  2014-12-22       Impact factor: 5.048

6.  Marine Morbilliviruses: Diversity and Interaction with Signaling Lymphocyte Activation Molecules.

Authors:  Kazue Ohishi; Tadashi Maruyama; Fumio Seki; Makoto Takeda
Journal:  Viruses       Date:  2019-07-03       Impact factor: 5.048

7.  Evaluating the influence of epidemiological parameters and host ecology on the spread of phocine distemper virus through populations of harbour seals.

Authors:  Catriona M Harris; Justin M J Travis; John Harwood
Journal:  PLoS One       Date:  2008-07-16       Impact factor: 3.240

8.  Phocine distemper outbreak, The Netherlands, 2002.

Authors:  Jolianne M Rijks; Marco W G Van de Bildt; Trine Jensen; Joost D W Philippa; Albert D M E Osterhaus; Thijs Kuiken
Journal:  Emerg Infect Dis       Date:  2005-12       Impact factor: 6.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.